23469045|t|Rivastigmine alleviates experimentally induced colitis in mice and rats by acting at central and peripheral sites to modulate immune responses.
23469045|a|The cholinergic anti-inflammatory system and alpha7 nicotinic receptors in macrophages have been proposed to play a role in neuroimmunomodulation and in the etiology of ulcerative colitis. We investigated the ability of a cholinesterase (ChE) inhibitor rivastigmine, to improve the pathology of ulcerative colitis by increasing the concentration of extracellular acetylcholine in the brain and periphery. In combination with carbachol (10 microM), rivastigmine (1 microM) significantly decreased the release of nitric oxide, TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-activated RAW 264.7 macrophages and this effect was abolished by alpha7 nicotinic receptor blockade by bungarotoxin. Rivastigmine (1 mg/kg) but not (0.5 mg/kg), injected subcutaneously once daily in BALB/c mice with colitis induced by 4% dextran sodium sulphate (DSS), reduced the disease activity index (DAI) by 60% and damage to colon structure. Rivastigmine (1 mg/kg) also reduced myeloperoxidase activity and IL-6 by >60%, and the infiltration of CD11b expressing cells by 80%. These effects were accompanied by significantly greater ChE inhibition in cortex, brain stem, plasma and colon than that after 0.5 mg/kg. Co-administration of rivastigmine (1 mg/kg) with the muscarinic antagonist scopolamine significantly increased the number of CD11b expressing cells in the colon but did not change DAI compared to those treated with rivastigmine alone. Rivastigmine 1 and 2 mg given rectally to rats with colitis induced by rectal administration of 30 mg dintrobezene sulfonic acid (DNBS) also caused a dose related reduction in ChE activity in blood and colon, the number of ulcers and area of ulceration, levels of TNF-alpha and in MPO activity. The study revealed that the ChE inhibitor rivastigmine is able to reduce gastro-intestinal inflammation by actions at various sites at which it preserves ACh. These include ACh released from vagal nerve endings that activates alpha7 nicotinic receptors on circulating macrophages and in brainstem neurons.
23469045	0	12	Rivastigmine	Chemical	MESH:D000068836
23469045	47	54	colitis	Disease	MESH:D003092
23469045	58	62	mice	Species	10090
23469045	67	71	rats	Species	10116
23469045	165	177	inflammatory	Disease	MESH:D007249
23469045	189	215	alpha7 nicotinic receptors	Gene	
23469045	313	331	ulcerative colitis	Disease	MESH:D003093
23469045	366	380	cholinesterase	Gene	12038
23469045	382	385	ChE	Gene	
23469045	397	409	rivastigmine	Chemical	MESH:D000068836
23469045	439	457	ulcerative colitis	Disease	MESH:D003093
23469045	507	520	acetylcholine	Chemical	MESH:D000109
23469045	569	578	carbachol	Chemical	MESH:D002217
23469045	592	604	rivastigmine	Chemical	MESH:D000068836
23469045	655	667	nitric oxide	Chemical	MESH:D009569
23469045	669	678	TNF-alpha	Gene	21926
23469045	680	688	IL-1beta	Gene	16176
23469045	693	697	IL-6	Gene	24498
23469045	703	721	lipopolysaccharide	Chemical	MESH:D008070
23469045	732	741	RAW 264.7	CellLine	CVCL:0493
23469045	839	851	Rivastigmine	Chemical	MESH:D000068836
23469045	928	932	mice	Species	10090
23469045	938	945	colitis	Disease	MESH:D003092
23469045	960	983	dextran sodium sulphate	Chemical	-
23469045	985	988	DSS	Chemical	-
23469045	1070	1082	Rivastigmine	Chemical	MESH:D000068836
23469045	1106	1121	myeloperoxidase	Gene	17523
23469045	1135	1139	IL-6	Gene	16193
23469045	1173	1178	CD11b	Gene	16409
23469045	1260	1263	ChE	Gene	
23469045	1363	1375	rivastigmine	Chemical	MESH:D000068836
23469045	1395	1405	muscarinic	Gene	
23469045	1417	1428	scopolamine	Chemical	MESH:D012601
23469045	1467	1472	CD11b	Gene	16409
23469045	1557	1569	rivastigmine	Chemical	MESH:D000068836
23469045	1577	1589	Rivastigmine	Chemical	MESH:D000068836
23469045	1619	1623	rats	Species	10116
23469045	1629	1636	colitis	Disease	MESH:D003092
23469045	1679	1705	dintrobezene sulfonic acid	Chemical	-
23469045	1707	1711	DNBS	Chemical	-
23469045	1753	1756	ChE	Gene	
23469045	1800	1806	ulcers	Disease	MESH:D014456
23469045	1841	1850	TNF-alpha	Gene	21926
23469045	1858	1861	MPO	Gene	17523
23469045	1900	1903	ChE	Gene	
23469045	1914	1926	rivastigmine	Chemical	MESH:D000068836
23469045	1945	1975	gastro-intestinal inflammation	Disease	MESH:D007249
23469045	2026	2029	ACh	Chemical	MESH:D000109
23469045	2045	2048	ACh	Chemical	MESH:D000109
23469045	2098	2124	alpha7 nicotinic receptors	Gene	
23469045	Negative_Correlation	MESH:D000068836	MESH:D003092
23469045	Negative_Correlation	MESH:D000068836	16193
23469045	Positive_Correlation	MESH:D000068836	MESH:D000109
23469045	Positive_Correlation	MESH:D002217	24498
23469045	Negative_Correlation	MESH:D000068836	MESH:D014456
23469045	Negative_Correlation	MESH:D000068836	12038
23469045	Negative_Correlation	MESH:D000068836	MESH:D003093
23469045	Negative_Correlation	MESH:D000068836	16176
23469045	Negative_Correlation	MESH:D000109	MESH:D007249
23469045	Positive_Correlation	MESH:D012601	16409
23469045	Negative_Correlation	MESH:D000068836	MESH:D009569
23469045	Negative_Correlation	MESH:D000068836	17523
23469045	Negative_Correlation	MESH:D000068836	24498
23469045	Positive_Correlation	MESH:D002217	MESH:D009569
23469045	Negative_Correlation	MESH:D000068836	MESH:D008070
23469045	Association	MESH:D000109	MESH:D003093
23469045	Negative_Correlation	MESH:D000068836	21926

